1. DayOneToday
2. elitebio30
3. bensynergy
4. BioTechBrains
1.bensynergy 10/05/2017
Never disclosed % patients PD-L1 positive. 53% of patients were treatment naive. 100% of patients treatment naive for checkpoints.
2.elitebio30 09/08/2017
@BioTechBrains Another great one for us! Did you listen to the Baird conf?
3.BioTechBrains 09/08/2017
Phase 2 updated data & presentation on 9th
4.elitebio30 10/02/2017
Pulled it down from $18 to $10
5.elitebio30 03/02/2018
NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW